You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In a pilot study, EMD Serono will have the genomes of lung cancer patients sequenced for research but participants will also gain access to their genomic data.
Several genetic test providers thought Helix would give them a national sales channel for their genomics apps, but this didn't materialize.
A company executive confirmed that Helix has laid off an undisclosed number of employees and is closing its Denver and San Francisco offices.
Illumina said that the DTC market is in "transition" from ancestry and genealogy to one driven by demand for health information.
The company published a letter on its website explaining that the genetic and other analyses involved in its services were too costly for customers to support.
Patients within the project and their physicians will be able to access Genome Medical's genetic specialists to address concerns and incorporate genetic information into care.
My Gene Counsel's confirmatory testing program is the latest example of how the healthcare system is adapting to consumers' growing appetite for genetic testing.
Healthcare providers continue to worry about the impact of 23andMe's health risk reports but there is also growing acceptance of the DTC testing model.
The new channel, to be launched in the second quarter, is part of the company's plan to make genetic testing affordable and accessible to everyone.
Direct-to-consumer genetic testing firm 23andMe has a newly cleared colorectal cancer risk test.
Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.
The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.
In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.
According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.